Tumor Profiling at the Service of Cancer Therapy

Fernández-Rozadilla, Ceres; Simões, Ana Rita; Carnero, Amancio; Carracedo, Ángel; Lleonart Pajarin, Matilde

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Fernández-Rozadilla, Ceres
dc.contributor.author	Simões, Ana Rita
dc.contributor.author	Carnero, Amancio
dc.contributor.author	Carracedo, Ángel
dc.contributor.author	Lleonart Pajarin, Matilde
dc.date.accessioned	2022-06-08T09:45:36Z
dc.date.available	2022-06-08T09:45:36Z
dc.date.issued	2021-01
dc.identifier.citation	Fernandez-Rozadilla C, Simões AR, Lleonart ME, Carnero A, Carracedo Á. Tumor Profiling at the Service of Cancer Therapy. Front Oncol. 2021 Jan;10:3038.
dc.identifier.issn	2234-943X
dc.identifier.uri	https://hdl.handle.net/11351/7641
dc.description	Tractament del càncer; Medicina personalitzada; Oncologia de precisió
dc.description.sponsorship	This work was funded by AECC grant GC16173720CARR to ÁC, ML, and AC. Also, other sources of funding include the Fundación Ramón Areces; the Spanish Ministry of Science, Innovation and Universities (MCIU- I+D+i 2018), Spanish Research State Agency (AEI), the European Fund for Regional Development (MCIU/AEI/FEDER-UE): grants RTI2018-097455-B-I00 and RED2018-102723-T; CIBER-Onc (grant number CB16/12/00275) and the Economy, Business and Universities Council of the Junta de Andalucia (grant number P18-RT-2501)—to AC; and the Instituto de Salud Carlos III (ISCIII) co-financed by the European Regional Fund (ERDF): grant numbers PI16/01057—to AC and PI15/01262 and CP03/00101—to ML.
dc.language.iso	eng
dc.publisher	Frontiers Media
dc.relation.ispartofseries	Frontiers in Oncology;10
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Càncer - Tractament
dc.subject	Medicina personalitzada
dc.subject.mesh	Neoplasms
dc.subject.mesh	/therapy
dc.subject.mesh	Precision Medicine
dc.title	Tumor Profiling at the Service of Cancer Therapy
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.3389/fonc.2020.595613
dc.subject.decs	neoplasias
dc.subject.decs	/terapia
dc.subject.decs	medicina de precisión
dc.relation.publishversion	https://doi.org/10.3389/fonc.2020.595613
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Fernandez-Rozadilla C, Simões AR] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. [Lleonart ME] Grup de Recerca Biomèdica en Cèl•lules Mare del Càncer, Vall d´Hebron Institut de Recerca (VHIR), Barcelona, Spain. Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. [Carnero A] Spanish Biomedical Research Network Centre in Oncology, CIBERONC, Madrid, Spain. Instituto de Biomedicina de Sevilla, IBIS, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Consejo Superior de Investigaciones Científicas, Seville, Spain. [Carracedo Á] Grupo de Medicina Xenómica (USC), Instituto de Investigación Sanitaria de Santiago (IDIS), Santiago de Compostela, Spain. Grupo de Medicina Xenómica (USC), Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain
dc.identifier.pmid	33505911
dc.identifier.wos	000611285600001
dc.rights.accessrights	info:eu-repo/semantics/openAccess